Adenosine A2A receptor availability in patients with early- and moderate-stage Parkinson’s disease

[1] Obeso JA(2008)The basal ganglia in Parkinson’s disease: Ccurrent concepts and unexplained observations Ann Neurol 64 S30-S46

[2] Marin C(1997)Distribution of adenosine receptors in the postmortem human brain: an extended autoradiographic study Synapse 27 322-335

[3] Rodriguez-Oroz C(2007)Evaluation of distribution of adenosine A Synapse 61 778-784

[4] Svenningsson P(2003) receptors in normal human brain measured with [ Neurology 20 482-487

[5] Hall H(1997)C]TMSX PET Trends Neurosci 12 1831-1834

[6] Sedvall G(2001)Anatomy of adenosine A NeuroReport 16 167-174

[7] Fredholm BB(2020) receptors in brain: morphological substrates for integration of striatal function Purinergic Signal 251 795-804

[8] Mishina M(2004)Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia J Neurol 5 235-245

[9] Ishiwata K(2006)Adenosine A Lancet Neurol 112 7833-7838

[10] Kimura Y(2016) agonist CGS 21680 decreases the affinity of dopamine D Neuropharmacology 39 131-155

[1] Obeso JA(2008)The basal ganglia in Parkinson’s disease: Ccurrent concepts and unexplained observations Ann Neurol 64 S30-S46

[2] Marin C(1997)Distribution of adenosine receptors in the postmortem human brain: an extended autoradiographic study Synapse 27 322-335

[3] Rodriguez-Oroz C(2007)Evaluation of distribution of adenosine A Synapse 61 778-784

[4] Svenningsson P(2003) receptors in normal human brain measured with [ Neurology 20 482-487

[5] Hall H(1997)C]TMSX PET Trends Neurosci 12 1831-1834

[6] Sedvall G(2001)Anatomy of adenosine A NeuroReport 16 167-174

[7] Fredholm BB(2020) receptors in brain: morphological substrates for integration of striatal function Purinergic Signal 251 795-804

[8] Mishina M(2004)Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia J Neurol 5 235-245

[9] Ishiwata K(2006)Adenosine A Lancet Neurol 112 7833-7838

[10] Kimura Y(2016) agonist CGS 21680 decreases the affinity of dopamine D Neuropharmacology 39 131-155